Apellis Pharmaceuticals Inc (APLS)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart

Ticker: APLS Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2022-10-11	2022-10-10	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 57.50 690,000 USD	12,000 -1.2%	57.50	690,000 USD
2022-10-05	2022-10-03	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 66.69 333,450 USD	5,000 -10.4%	66.69	333,450 USD
2022-10-05	2022-10-03	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.4% 66.69 166,725 USD	2,500 -2.4%	66.69	166,725 USD
2022-09-16	2022-09-15	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 66.00 82,500 USD	1,250 -0.5%	66.00	82,500 USD
2022-09-12	2022-09-08	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.2% 63.98 767,760 USD	12,000 -1.2%	63.98	767,760 USD
2022-09-08	2022-09-08	S Sale	Dunlop A. Sinclair Non-Executive Director	15,000 -5.9% 65.00 975,000 USD	15,000 -5.9%	65.00	975,000 USD
2022-09-07	2022-09-06	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 60.38 301,900 USD	5,000 -10.4%	60.38	301,900 USD
2022-09-02	2022-09-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.3% 60.30 150,750 USD	2,500 -2.3%	60.30	150,750 USD
2022-08-18	2022-08-17	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 69.50 347,500 USD	5,000 -14.6%	69.50	347,500 USD
2022-08-16	2022-08-15	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	12,500 -22.6% 69.00 862,500 USD	12,500 -22.6%	69.00	862,500 USD
2022-08-16	2022-08-15	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 67.21 84,013 USD	1,250 -0.5%	67.21	84,013 USD
2022-08-12	2022-08-11	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	12,500 -22.6% 67.00 837,500 USD	12,500 -22.6%	67.00	837,500 USD
2022-08-12	2022-08-11	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 67.00 335,000 USD	5,000 -14.6%	67.00	335,000 USD
2022-08-12	2022-08-11	S Sale	Dunlop A. Sinclair Non-Executive Director	30,000 -10.5% 65.63 1,968,900 USD	30,000 -10.5%	65.63	1,968,900 USD
2022-08-09	2022-08-08	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 64.50 322,500 USD	5,000 -14.6%	64.50	322,500 USD
2022-08-09	2022-08-08	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	12,500 -22.6% 65.00 812,500 USD	12,500 -22.6%	65.00	812,500 USD
2022-08-09	2022-08-08	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.3% 62.50 750,000 USD	12,000 -1.3%	62.50	750,000 USD
2022-08-08	2022-08-04	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 62.00 310,000 USD	5,000 -14.6%	62.00	310,000 USD
2022-08-08	2022-08-04	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -12.7% 59.50 297,500 USD	5,000 -12.7%	59.50	297,500 USD
2022-08-04	2022-08-03	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -11.7% 56.43 282,150 USD	5,000 -11.7%	56.43	282,150 USD
2022-08-02	2022-08-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.3% 55.99 139,975 USD	2,500 -2.3%	55.99	139,975 USD
2022-07-28	2022-07-27	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 57.00 285,000 USD	5,000 -14.6%	57.00	285,000 USD
2022-07-21	2022-07-19	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	5,000 -14.6% 56.42 282,100 USD	5,000 -14.6%	56.42	282,100 USD
2022-07-18	2022-07-15	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 46.33 57,913 USD	1,250 -0.5%	46.33	57,913 USD
2022-07-12	2022-07-11	PS Planned sale	Townsend Adam J. Chief Commercial Officer Officer	5,000 -10.4% 48.42 242,100 USD	5,000 -10.4%	48.42	242,100 USD
2022-07-12	2022-07-08	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.3% 47.95 575,400 USD	12,000 -1.3%	47.95	575,400 USD
2022-06-29	2022-06-27	S Sale	Dunlop A. Sinclair Non-Executive Director	1,341 -50.0% 46.79 62,743 USD	1,341 -50.0%	46.79	62,743 USD
2022-06-24	2022-06-23	S Sale	Dunlop A. Sinclair Non-Executive Director	15,000 -5.0% 45.00 675,000 USD	15,000 -5.0%	45.00	675,000 USD
2022-06-23	2022-06-22	S Sale	Watson David O. General Counsel Officer	10,000 -8.0% 44.51 445,140 USD	10,000 -8.0%	44.51	445,140 USD
2022-06-22	2022-06-17	S Sale	Brown Victoria L. Program Team Lead Officer	2,698 -9.7% 45.00 121,410 USD	2,698 -9.7%	45.00	121,410 USD
2022-06-21	2022-06-16	S Sale	DeLong Mark Jeffrey Senior Vice President Officer	10,000 -25.5% 41.79 417,850 USD	10,000 -25.5%	41.79	417,850 USD
2022-06-17	2022-06-15	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 39.29 49,113 USD	1,250 -0.5%	39.29	49,113 USD
2022-06-09	2022-06-08	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	12,000 -1.3% 44.09 529,080 USD	12,000 -1.3%	44.09	529,080 USD
2022-06-02	2022-06-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.2% 41.78 104,450 USD	2,500 -2.2%	41.78	104,450 USD
2022-05-31	2022-05-27	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	10,000 -19.9% 43.00 430,000 USD	10,000 -19.9%	43.00	430,000 USD
2022-05-17	2022-05-16	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 39.18 48,975 USD	1,250 -0.5%	39.18	48,975 USD
2022-05-03	2022-05-02	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	2,500 -2.2% 43.56 108,900 USD	2,500 -2.2%	43.56	108,900 USD
2022-05-02	2022-04-29	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	4,000 -0.4% 44.43 177,720 USD	4,000 -0.4%	44.43	177,720 USD
2022-04-27	2022-04-25	PS Planned sale	Watson David O. General Counsel Officer	5,000 -3.8% 50.00 250,000 USD	5,000 -3.8%	50.00	250,000 USD
2022-04-22	2022-04-20	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	7,000 -19.7% 52.53 367,710 USD	7,000 -19.7%	52.53	367,710 USD
2022-04-18	2022-04-14	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 50.90 63,625 USD	1,250 -0.5%	50.90	63,625 USD
2022-04-06	2022-04-05	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	609 -1.2% 60.09 36,593 USD	609 -1.2%	60.09	36,593 USD
2022-04-05	2022-04-04	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	1,249 -2.3% 57.81 72,198 USD	1,249 -2.3%	57.81	72,198 USD
2022-04-05	2022-04-04	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	1,437 -2.6% 56.86 81,714 USD	1,437 -2.6%	56.86	81,714 USD
2022-04-05	2022-04-04	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	818 -1.5% 55.84 45,677 USD	818 -1.5%	55.84	45,677 USD
2022-04-04	2022-04-01	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	11,496 -18.0% 55.05 632,855 USD	11,496 -18.0%	55.05	632,855 USD
2022-03-17	2022-03-15	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.3% 39.57 14,839 USD	375 -0.3%	39.57	14,839 USD
2022-03-17	2022-03-15	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.5% 39.57 49,463 USD	1,250 -0.5%	39.57	49,463 USD
2022-03-02	2022-03-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.3% 43.53 16,324 USD	375 -0.3%	43.53	16,324 USD
2022-02-16	2022-02-15	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.4% 45.43 17,036 USD	375 -0.4%	45.43	17,036 USD
2022-02-16	2022-02-15	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.2% 45.43 56,788 USD	1,250 -0.2%	45.43	56,788 USD
2022-02-14	2022-02-11	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	1,666 -3.1% 46.80 77,969 USD	1,666 -3.1%	46.80	77,969 USD
2022-02-14	2022-02-10	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	10,000 -15.8% 50.00 500,000 USD	10,000 -15.8%	50.00	500,000 USD
2022-02-10	2022-02-08	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	10,000 -15.7% 45.00 450,000 USD	10,000 -15.7%	45.00	450,000 USD
2022-02-02	2022-02-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.4% 40.58 15,218 USD	375 -0.4%	40.58	15,218 USD
2022-02-01	2022-01-31	PS Planned sale	SCHEIBLER LUKAS CHIEF INNOVATION OFFICER Officer	1,233 -2.2% 38.47 47,434 USD	1,233 -2.2%	38.47	47,434 USD
2022-01-19	2022-01-14	PS Planned sale	Machiels Alec Non-Executive Director	1,250 -0.2% 40.56 50,700 USD	1,250 -0.2%	40.56	50,700 USD
2022-01-19	2022-01-14	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.5% 40.56 15,210 USD	375 -0.5%	40.56	15,210 USD
2022-01-04	2022-01-03	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.5% 47.31 17,741 USD	375 -0.5%	47.31	17,741 USD
2021-12-23	2021-12-22	S Sale	Watson David O. General Counsel Officer	300 -0.3% 48.58 14,573 USD	300 -0.3%	48.58	14,573 USD
2021-12-23	2021-12-22	S Sale	Watson David O. General Counsel Officer	5,097 -4.5% 47.86 243,917 USD	5,097 -4.5%	47.86	243,917 USD
2021-12-23	2021-12-22	S Sale	Watson David O. General Counsel Officer	5,174 -4.7% 47.72 246,883 USD	5,174 -4.7%	47.72	246,883 USD
2021-12-17	2021-12-15	PS Planned sale	Machiels Alec Non-Executive Director	3,000 -0.4% 42.88 128,640 USD	3,000 -0.4%	42.88	128,640 USD
2021-12-17	2021-12-15	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.5% 42.88 16,080 USD	375 -0.5%	42.88	16,080 USD
2021-12-03	2021-12-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	375 -0.6% 42.40 15,900 USD	375 -0.6%	42.40	15,900 USD
2021-11-18	2021-11-18	B Purchase	Morningside Venture Investments Ltd Major owner	250,000 +2.0% 40.00 10,000,000 USD	250,000 +2.0%	40.00	10,000,000 USD
2021-11-17	2021-11-15	PS Planned sale	Machiels Alec Non-Executive Director	3,000 -0.4% 43.50 130,500 USD	3,000 -0.4%	43.50	130,500 USD
2021-11-17	2021-11-15	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	625 -1.0% 43.50 27,188 USD	625 -1.0%	43.50	27,188 USD
2021-11-17	2021-11-04	PS Planned sale	Machiels Alec Non-Executive Director	3,000 -0.4% 35.00 105,000 USD	3,000 -0.4%	35.00	105,000 USD
2021-11-02	2021-11-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	625 -1.0% 30.70 19,188 USD	625 -1.0%	30.70	19,188 USD
2021-10-15	2021-10-14	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	750 -1.1% 34.57 25,928 USD	750 -1.1%	34.57	25,928 USD
2021-10-05	2021-10-01	PS Planned sale	Grossi Federico CHIEF MEDICAL OFFICER Officer	750 -1.1% 33.26 24,945 USD	750 -1.1%	33.26	24,945 USD
2021-07-22	2021-07-21	PS Planned sale	DeLong Mark Jeffrey Senior Vice President Officer	1,000 -9.5% 65.00 65,000 USD	1,000 -9.5%	65.00	65,000 USD
2021-06-25	2021-06-24	PS Planned sale	Deschatelets Pascal Chief Scientific Officer Officer	6,250 -0.7% 65.61 410,063 USD	6,250 -0.7%	65.61	410,063 USD
2021-06-16	2021-06-15	S Sale	DeLong Mark Jeffrey Senior Vice President Officer	4,000 -29.7% 64.96 259,830 USD	4,000 -29.7%	64.96	259,830 USD